{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:13:25Z","timestamp":1790190805637,"version":"4.1.0"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Coronary heart disease (CHD) poses a serious threat to public health, and the current medical management still faces significant challenges. Reliable evidence on the efficacy of Shuxuening injection (SXNI) in CHD is still lacking, even though it is widely used in China.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Purpose:<\/jats:bold>\n                    To evaluate the efficacy of SXNI combination therapy in treating CHD.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    A systematic search of eight databases was conducted to identify relevant randomized controlled trials (RCTs) from the inception of each database until June 2023. ROB 2.0, RevMan 5.4, and Stata 15.1 were used for quality evaluation and data analysis. The Grading of Recommendation, Assessment, Development, and Evaluation (GRADE) approach was used to evaluate the quality of evidence.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    A total of 3,779 participants from 39 studies were included. The results showed SXNI combination therapy increased the clinical efficacy and decreased the frequency and duration of angina. Furthermore, SXNI combination therapy improved cardiac function of patients by decreasing LVEDD, and increased CI, CO, and LVEF. It also improved blood lipid profiles by increasing HDL, decreasing TC, TG, and LDL. The thrombosis factors of patients were also improved by decreasing FIB, PV, HCT, and HS. Moreover, SXNI combination therapy was superior to the conventional treatment in improving CRP levels, increasing ECG efficacy and BNP. However, due to the limited safety information, reliable safety conclusions could not be drawn. Furthermore, the levels of evidence ranged from very low to\n                    <jats:ext-link>moderate<\/jats:ext-link>\n                    due to publication bias and heterogeneity.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    SXNI can effectively improve angina symptoms, clinical efficacy, cardiac function, blood lipid indicators, and thrombosis factors of patients with CHD. However, more multi-center and large-sample studies are needed to confirm the conclusions due to the limitations of this study.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Registration<\/jats:bold>\n                    <jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=399606<\/jats:ext-link>\n                    ; Identifier: CRD42023433292.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2023.1265603","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T04:37:16Z","timestamp":1695098236000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Effectiveness of Shuxuening injection in coronary heart disease: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Menglong","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianye","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaochen","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.pcad.2016.04.003","article-title":"Coronary atherosclerosis: pathophysiologic basis for diagnosis and management","volume":"58","author":"Boudoulas","year":"2016","journal-title":"Prog. CARDIOVASC Dis."},{"key":"B2","first-page":"302","article-title":"Efficacy and safety of Shuxuening combined with atorvastatin in the treatment of angina pectoris after acute myocardial infarction","volume":"43","author":"Cai","year":"2021","journal-title":"Sichuan J. Physiol. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3969\/j.issn.1000-338X.2010.03.011","article-title":"Shuxuening combined with western medicine in treating 58 cases of unstable angina","volume":"41","author":"Chai","year":"2010","journal-title":"FUJIAN J. Tradit. Chin. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.14163\/j.cnki.11-5547\/r.2016.20.094","article-title":"Clinical effect analysis of Shuxuening injection combined with nitroglycerin injection on angina pectoris of coronary heart disease","volume":"11","author":"Chen","year":"2016","journal-title":"Chin. Prac. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3969\/j.issn.1672-2124.2008.09.020","article-title":"Curative effect of shuxuening injection on angina pectoris","volume":"8","author":"Cui","year":"2008","journal-title":"Eval. Anal. Drug-Use Hosp. Chin"},{"key":"B6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3969\/j.issn.1672-951X.2014.09.027","article-title":"Clinical observation of sulxuening combined with simvastatin in the treatment of angina pectoris of coronary heart disease","author":"Dai","year":"2014","journal-title":"Guid. J. Tradit. Chin. Med. Pharm."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1001\/jama.279.18.1477","article-title":"Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies","volume":"279","author":"Danesh","year":"1998","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","first-page":"6650763","DOI":"10.1155\/2022\/6650763","article-title":"Systematic review of the efficacy and safety of shuxuening injection in the treatment of unstable angina","volume":"2022","author":"Fan","year":"2022","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/0002-8703(94)90679-3","article-title":"Hematocrit and the risk of cardiovascular disease-the Framingham study: a 34-year follow-up","volume":"127","author":"Gagnon","year":"1994","journal-title":"Am. HEART J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3969\/j.issn.1673-7210.2009.28.020","article-title":"Clinical study of Shuxuening improving coronary blood supply","volume":"6","author":"Gao","year":"2009","journal-title":"Chin. Med. Her."},{"key":"B11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3969\/j.issn.1007-614x.2011.27.172","article-title":"Curative effect of Shuxuening injection combined with isosorbide mononitrate on unstable angina pectoris","volume":"13","author":"Gao","year":"2011","journal-title":"Chin. Comm. Dr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/S0140-6736(17)32130-X","article-title":"Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"390","year":"2017","journal-title":"LANCET"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.euf.2021.09.014","article-title":"Evidence-based urology: understanding GRADE methodology","volume":"7","author":"Gonzalez-Padilla","year":"2021","journal-title":"Eur. Urol. Focus"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12037\/YXQY.2018.06-01","article-title":"Guidelines for rational drug use in coronary heart disease (2nd edition)","volume":"10","author":"Guo","year":"2018","journal-title":"J. Front. Med. Sci. Electron. Ed."},{"key":"B15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3969\/j.issn.1005-9903.2012.15.058","article-title":"Protection of shuxuening injection on myocardial ischemia","volume":"18","author":"Guo","year":"2012","journal-title":"Chin. J. Exp. Tradit. Med. Form."},{"key":"B16","doi-asserted-by":"publisher","first-page":"606","DOI":"10.13748\/j.cnki.issn1007-7693.2014.05.024","article-title":"Clinical observation of shuxuening injection combined with rosuvastatin on unstable angina","volume":"31","author":"He","year":"2014","journal-title":"Chin. J. Mod. Appl. Pharm."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.7501\/j.issn.1674-5515.2022.09.021","article-title":"Clinical study of Shuxuening injection combined with Tirofiban in the treatment of acute myocardial infarction patients undergoing emergency percutaneous coronary intervention","volume":"37","author":"He","year":"2022","journal-title":"Drugs & Clin."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jama.2021.1527","article-title":"Diagnosis and management of stable angina: a review","volume":"325","author":"Joshi","year":"2021","journal-title":"JAMA"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1142\/S0192415X1950054X","article-title":"Ginkgo biloba pretreatment attenuates myocardial ischemia-reperfusion injury via mitoBK(Ca)","volume":"47","author":"Li","year":"2019","journal-title":"Am. J. Chin. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3969\/j.issn.1000-7369.2015.07.024","article-title":"Clinical efficacy of Shuxuening injection combined with atorvastatin in the treatment of unstable angina pectoris and its influence on serum hs-CRP","author":"Li","year":"2015","journal-title":"Shaanxi J. Tradit. Chin. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3969\/j.issn.1007-614x.2018.27.051","article-title":"Clinical effect of Shu Xue Ning Injection in the treatment of unstable angina pectoris of acute coronary syndrome","volume":"34","author":"Liu","year":"2018","journal-title":"Chin. Comm. Dr."},{"key":"B22","first-page":"73","article-title":"Study on Shuxuening injection intervention of serum BNP,hs-CRP and carotid atherosclerosis plaque in patients with unstable angina pectoris","volume":"51","author":"Liu","year":"2013","journal-title":"Chin. Mod. Dr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"116486","DOI":"10.1016\/j.jep.2023.116486","article-title":"Xinkeshu for coronary heart disease complicated with anxiety or depression: a meta-analysis of randomized controlled trials","volume":"312","author":"Liu","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"728","DOI":"10.16367\/j.issn.1003-5028.2015.04.0309","article-title":"48 cases with unstable angina pectoris treated with shuxuening injection","volume":"35","author":"Liu","year":"2015","journal-title":"Henan Tradit. Chin. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/hm9.0000000000000028","article-title":"Effects of adjuvant Chinese patent medicine therapy on major adverse cardiovascular events in patients with coronary heart disease angina pectoris: A population-based retrospective cohort study","volume":"2","author":"Liu","year":"2022","journal-title":"AHM"},{"key":"B26","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13068-015-0342-8","article-title":"Assessment of drought tolerance of 49 switchgrass (Panicum virgatum) genotypes using physiological and morphological parameters","volume":"8","author":"Liu","year":"2015","journal-title":"Chin. Mod. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"208223","DOI":"10.1136\/jcp-2022-208223","article-title":"Plasma viscosity, immunoglobulins and risk of cardiovascular disease and mortality: new data and meta-analyses","volume":"2022","author":"Lowe","year":"2023","journal-title":"J. Clin. Pathol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3389\/fphar.2018.00312","article-title":"Tnfrsf12a-Mediated atherosclerosis signaling and inflammatory response as a common protection mechanism of shuxuening injection against both myocardial and cerebral ischemia-reperfusion injuries","volume":"9","author":"Lyu","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.11909\/j.issn.1671-5411.2020.01.001","article-title":"China cardiovascular diseases report 2018: an updated summary","volume":"17","author":"Ma","year":"2020","journal-title":"J. Geriatr. Cardiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3969\/j.issn.1007-8517.2012.11.075","article-title":"Clinical study of Shuxuening injection combined with Western medicine in the treatment of unstable angina pectoris","volume":"21","author":"Ma","year":"2012","journal-title":"Chin. J. Ethnomed. Ethnopharm."},{"key":"B31","doi-asserted-by":"publisher","first-page":"154749","DOI":"10.1016\/j.phymed.2023.154749","article-title":"Regulation of phospholipid peroxidation signaling by a traditional Chinese medicine formula for coronary heart disease","volume":"114","author":"Ma","year":"2023","journal-title":"PHYTOMEDICINE"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.3969\/j.issn.1008-8849.2012.23.035","article-title":"Shuxuening injection assisted treatment of 42 cases of angina pectoris in elderly patients with coronary heart disease","volume":"21","author":"Meng","year":"2012","journal-title":"Mod. J. Integr. tradit. Chin. West. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13643-018-0699-4","article-title":"Registration of systematic reviews in PROSPERO: 30,000 records and counting","volume":"7","author":"Page","year":"2018","journal-title":"Syst. Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychores.2017.10.015","article-title":"Depression and anxiety symptom trajectories in coronary heart disease: associations with measures of disability and impact on 3-year health care costs","volume":"104","author":"Palacios","year":"2018","journal-title":"J. Psychosom. Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3969\/j.issn.1002-7386.2014.04.012","article-title":"Analysis of curative effect of Shuxuening injection on angina pectoris","author":"Ren","year":"2014","journal-title":"Hebei Med. J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"Amstar 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"B38","doi-asserted-by":"publisher","first-page":"154829","DOI":"10.1016\/j.phymed.2023.154829","article-title":"The efficacy of sodium ferulate combination therapy in coronary heart disease: a systematic review and meta-analysis","volume":"115","author":"Shen","year":"2023","journal-title":"PHYTOMEDICINE"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.47750\/jptcp.2022.888","article-title":"The characteristics of impaired functions and life limitations of disabled people due to coronary heart disease","volume":"29","author":"Shmakova","year":"2022","journal-title":"J. Popul. Ther. Clin. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2022.12.031","article-title":"Identifying and comparing low-value care recommendations for coronary heart disease prevention, diagnosis, and treatment in the US and China","volume":"374","author":"Su","year":"2023","journal-title":"Int. J. Cardiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3969\/j.issn.1671-8194.2011.30.264","article-title":"Curative effect of Shuxuening injection combined with low molecular weight heparin in the treatment of unstable angina Curative effect of Shuxuening injection combined with low molecular weight heparin in the treatment of unstable angina pectoris","volume":"9","author":"Sui","year":"2011","journal-title":"GUIDE Chin. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3969\/j.issn.1674-4721.2010.27.046","article-title":"Curative effect of Shuxuening on angina pectoris","volume":"17","author":"Sun","year":"2010","journal-title":"Chin. Mod. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3969\/j.issn.1006-4931.2019.09.016","article-title":"Clinical evaluation on shuxuening combined with rosuvastatin in the treatment of acute myocardial infarction complicated with angina pectoris","volume":"28","author":"Sun","year":"2019","journal-title":"Chin. Pharm."},{"key":"B44","doi-asserted-by":"publisher","first-page":"10289","DOI":"10.1002\/jcp.27945","article-title":"Relationship between serum high sensitivity C-reactive protein with angiographic severity of coronary artery disease and traditional cardiovascular risk factors","volume":"234","author":"Tajfard","year":"2019","journal-title":"J. Cell Physiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"154641","DOI":"10.1016\/j.phymed.2023.154641","article-title":"Efficacy and safety of shenfu injection on acute heart failure: a systematic review and meta-analysis","volume":"110","author":"Tao","year":"2023","journal-title":"PHYTOMEDICINE"},{"key":"B46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3969\/j.issn.1006-3765.2015.03.069","article-title":"Clinical efficacy of Shuxuening injection combined with atorvastatin in the treatment of unstable angina pectoris and its influence on serum hs-CRP","author":"Wang","year":"2015","journal-title":"Strait Pharm. J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/DDDT.S156000","article-title":"Reevaluation of the post-marketing safety of Shuxuening injection based on real-world and evidence-based evaluations","volume":"12","author":"Wang","year":"2018","journal-title":"Drug Des. Devel Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.16282\/j.cnki.cn11-9336\/r.2021.17.019","article-title":"Clinical effect of Shuxuening injection on angina pectoris of coronary heart disease","volume":"9","author":"Wang","year":"2021","journal-title":"Cardiovasc. dis. J. integr. tradit. Chin. West. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3969\/j.issn.1671-8194.2009.03.042","article-title":"Curative effect of Shuxuening on angina pectoris of coronary heart disease","volume":"7","author":"Wang","year":"2009","journal-title":"Guide Chin. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"8","DOI":"10.13638\/j.issn.1671-4040.2021.08.003","article-title":"Curative effect of Shuxuening injection combined with isosorbide mononitrate on patients with unstable angina pectoris of coronary heart disease. Practical clin","volume":"21","author":"Wang","year":"2021","journal-title":"J. Integr. tradit. Chin. West. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"562","DOI":"10.21037\/atm.2019.09.40","article-title":"Shuxuening injection protects against myocardial ischemia-reperfusion injury through reducing oxidative stress, inflammation and thrombosis","volume":"7","author":"Wang","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"154630","DOI":"10.1016\/j.phymed.2022.154630","article-title":"Efficacy and safety evaluation of shenmai injections for dilated cardiomyopathy: a systematic review and meta-analysis of randomised controlled trials","volume":"110","author":"Wang","year":"2023","journal-title":"PHYTOMEDICINE"},{"key":"B53","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jclinepi.2015.06.005","article-title":"ROBIS: a new tool to assess risk of bias in systematic reviews was developed","volume":"69","author":"Whiting","year":"2016","journal-title":"J. Clin. Epidemiol."},{"key":"B54","volume-title":"WHO reveals leading causes of death and disability worldwide: 2000-2019","year":"2020"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.14009\/j.issn.1672-2124.2017.11.004","article-title":"Meta-analysis of clinical efficacy of shuxuening injection in treatment of angina pectoris","volume":"17","author":"Wu","year":"2017","journal-title":"Eval. Analysis Drug-Use Hosp. Chin"},{"key":"B56","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3969\/j.issn.1672-0369.2016.09.033","article-title":"Clinical study of Shuxuening injection combined with Western medicine in the treatment of unstable angina pectoris","volume":"28","author":"Wu","year":"2016","journal-title":"Med. J. Chin. People's Health"},{"key":"B57","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3969\/j.issn.1004-7115.2012.03.022","article-title":"Clinical observation of Shuxuening injection in treating 25 cases of angina pectoris of coronary heart disease","volume":"33","author":"Xu","year":"2012","journal-title":"J. Taishan Med. Coll."},{"key":"B58","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3389\/fphar.2019.00735","article-title":"Ginkgo flavonol glycosides or Ginkgolides tend to differentially protect myocardial or cerebral ischemia-reperfusion injury via regulation of TWEAK-fn14 signaling in heart and brain","volume":"10","author":"Xiao","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"73","DOI":"10.16305\/j.1007-1334.2009.04.026","article-title":"Influence of ginkgo biloba leaves extract on expressions of vascular endothelial NF-KBp65, iNOS andMCP-1 in hyperhomocysteinemia rats","volume":"43","author":"Xu","year":"2009","journal-title":"Shanghai J. Tradit. Chin. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/gme.0b013e3181ef5a78","article-title":"Correlation between sonographic and endocrine markers of ovarian aging as predictors for late menopausal transition","volume":"17","author":"Yang","year":"2011","journal-title":"Contemp. Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.chroma.2019.04.008","article-title":"Integrated liquid chromatography-mass spectrometry and nuclear magnetic resonance spectra for the comprehensive characterization of various components in the Shuxuening injection","volume":"1599","author":"Yu","year":"2019","journal-title":"J. Chromatogr. A"},{"key":"B62","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1590\/S1415-47572013005000018","article-title":"Non-detection of Epstein-Barr virus and Human Papillomavirus in a region of high gastric cancer risk indicates a lack of a role for these viruses in gastric carcinomas","volume":"9","author":"Yuan","year":"2013","journal-title":"Asia-Pac. Tradit. Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3969\/j.issn.1005-1740.2011.01.009","article-title":"Effect of shuxuening infection on serum levels of hs-CRP and hemorheology in elderly patients with coronary artery disease","volume":"21","author":"Zhang","year":"2011","journal-title":"Chin. J. Microcirc."},{"key":"B64","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3969\/j.issn.1672-8351.2018.10.115","article-title":"Effects of alprostadil combined with Shuxuening injection on symptom improvement and left ventricular ejection fraction in patients with coronary heart disease and myocardial ischemia","volume":"15","author":"Zhang","year":"2018","journal-title":"J. No. Pharm."},{"key":"B65","first-page":"114","article-title":"Clinical curative effect of Shuxuening injection on severe coronary heart disease","volume":"26","author":"Zhang","year":"2016","journal-title":"Chin. Health Nutr."},{"key":"B66","first-page":"122","article-title":"Clinical effect of Shuxuening in the treatment of unstable angina pectoris and its influence on cardiac function and hemodynamics","volume":"20","author":"Zhang","year":"2022","journal-title":"J. Chin. Prescr. Drug"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.3969\/j.issn.1008-8849.2012.22.023","article-title":"Curative effect of isosorbide mononitrate combined with Shuxuening injection on stable angina pectoris","volume":"21","author":"Zhang","year":"2012","journal-title":"Mod. J. Integr. tradit. Chin. West. Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.3969\/j.issn.1004-0412.2011.20.051","article-title":"Curative effect of Shuxuening injection on angina pectoris of coronary heart disease","volume":"32","author":"Zhao","year":"2011","journal-title":"JILIN Med. J."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.3969\/j.issn.1006-1959.2010.10.315","article-title":"Clinical effect of Shuxuening injection on angina pectoris of coronary heart disease","volume":"5","author":"Zhong","year":"2010","journal-title":"Med. Inf."},{"key":"B70","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3969\/j.issn.1006-0979.2017.06.078","article-title":"Effect of Shuxuening combined with trimetazidine in the treatment of angina pectoris of coronary heart disease","volume":"36","author":"Zhou","year":"2017","journal-title":"Nei Mongu J. Tradit. Chin. Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3969\/j.issn.1672-2779.2010.05.069","article-title":"Shuxuening treated 100 cases of unstable angina pectoris","volume":"8","author":"Zhou","year":"2010","journal-title":"Chin. Med. Mod. Distance Educ. Chin."},{"key":"B72","doi-asserted-by":"publisher","first-page":"62","DOI":"10.19945\/j.cnki.issn.1006-3250.2015.01.027","article-title":"Meta-analysis of therapy plan assisted by shuxuening injection on conronary heart disease with unstable angina pectoris","volume":"21","author":"Zhou","year":"2015","journal-title":"Chin. J. Basic Med. Tradit. Chin. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.3969\/j.issn.1000-7377.2014.12.049","article-title":"Effect of Shuxuening injection on unstable angina pectoris and serum hs-CRP","volume":"2014","author":"Zhu","year":"2014","journal-title":"Shanxi Med. J."},{"key":"B74","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/heapol\/czac101","article-title":"Change in coronary heart disease hospitalization after chronic disease management: a programme policy in China","volume":"38","author":"Zhu","year":"2023","journal-title":"Health Policy Plan."},{"key":"B75","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3969\/j.issn.1008-0074.2010.05.35","article-title":"Effects of Shuxuening injection on hemorheology and inflammatory factors in patients with coronary heart disease","volume":"19","author":"Zhuang","year":"2010","journal-title":"Chin. J. Cardiovasc. Rehabil. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1265603\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T04:38:30Z","timestamp":1695098310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1265603\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,18]]},"references-count":75,"alternative-id":["10.3389\/fphar.2023.1265603"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1265603","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,18]]},"article-number":"1265603"}}